CPT Code 91320: COVID-19 Vaccine, Tris-Sucrose Formulation, for Intramuscular Use

Know more about the essential information and coverage details of CPT 91320 for COVID-19 vaccines.

What is CPT 91320?

CPT 91320 is a specific COVID-19 vaccine product code maintained by the American Medical Association (AMA) under the Vaccines and Toxoids category. This code describes the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine, specifically the mRNA-LNP, spike protein formulation with a 30 mcg/0.3 mL dosage using tris-sucrose formulation for intramuscular administration in patients 12 years and older.

The code was developed as part of a comprehensive overhaul of COVID-19 vaccine coding that consolidated more than 50 previous codes into a streamlined system. This change reflected the transition from tracking individual vaccine products during the public health emergency to a more standardized approach for ongoing vaccination programs.

The vaccine product represented by CPT 91320 utilizes a tris-sucrose buffer system, which differs from the phosphate buffer present in older vaccine procedure codes. This formulation offers enhanced stability and storage characteristics, making it particularly suitable for diverse locations, including physician offices, outpatient hospitals, and community clinics.

The vaccine provides protection against SARS-CoV-2, the coronavirus that causes severe acute respiratory syndrome coronavirus 2 disease. Clinical applications include primary vaccination series, booster doses, and updated formulations targeting specific viral variants as authorized by the Food and Drug Administration.

CPT code 91320 documentation requirements

Comprehensive documentation for this code requires adherence to federal vaccination guidelines, state-specific requirements, and payer policies. This involves the following:

Patient eligibility verification: Documentation must confirm the patient meets age range requirements (12 years and older) and verify eligibility for vaccination based on current CDC recommendations and contraindication screening. This includes assessment of previous vaccination history, allergic reactions, and current health status.
Vaccine product information: Records must identify the specific vaccine administered using CPT 91320, including the lot number, expiration date, manufacturer information, and VFC-provided stock utilization when applicable. For individuals eligible for the Vaccines for Children program, documentation must reflect the use of federally provided vaccine supplies.
Administration details: Complete documentation includes injection site (typically deltoid muscle), administration technique, dose volume (0.5 mL for this formulation), and any immediate post-vaccination observations. The record should specify the intramuscular route and document proper storage and handling procedures.
Provider type verification: Documentation must identify the healthcare provider administering the vaccine, including nurse practitioners, physician assistants, registered nurses, clinical nurse specialists, or certified nurse-midwives, as applicable. Each provider type must meet state licensing requirements and facility credentialing standards.
Location documentation: Records must specify the administration setting, whether in a physician's office, an outpatient hospital, a patient's home, a renal dialysis facility, or other authorized locations. For home setting administration, additional documentation may be required to support additional payment claims.
Counseling documentation: Immunization counseling requirements must be documented, including discussion of vaccine benefits, risks, and potential side effects. This counseling is typically included in the administration procedure code 90480 and cannot be billed separately using other counseling codes on the same day.

CPT code 91320 billing guidelines

Billing for CPT code 91320 requires an understanding of both federal coverage policies and state-specific requirements, particularly for Medicaid and CHIP programs. Proper code combination with administration codes ensures accurate reimbursement while avoiding common billing errors.

Vaccine administration procedure code pairing

CPT 91320 must be billed in conjunction with vaccine administration procedure code 90480, which represents the administration of any COVID-19 vaccine for any patient. This single administration code replaced multiple product-specific administration codes, streamlining the billing process while maintaining accurate service reporting.

The administration code 90480 includes immunization counseling services, eliminating the need for separate counseling codes such as G0315. Billing both codes on the same day by the same provider would constitute inappropriate duplicate billing and should be avoided.

Provider type eligibility

Multiple provider types are eligible to bill CPT code 91320, including physicians, nurse practitioners, physician assistants, registered nurses under appropriate supervision, clinical nurse specialists, and certified nurse midwives. Each provider must meet state licensing requirements and facility credentialing standards.

For instance, Texas Health Steps providers have specific eligibility criteria for pediatric patients aged 6 months through 20 years, though CPT 91320 applies only to patients 12 years and older within this population. Providers must then verify Texas Medicaid enrollment and maintain appropriate provider agreements.

Understanding this comprehensive code structure ensures accurate billing across all coronavirus 2 SARS-CoV vaccination scenarios while maintaining compliance with federal, state, and payer-specific requirements. Proper code selection supports public health tracking efforts and ensures appropriate reimbursement for services rendered across diverse provider types and location settings.

Frequently asked questions

The administration of the COVID-19 vaccine, represented by CPT code 91320, should be billed using administration code 90480. As of late 2023, CPT 90480 is the designated code for administering any COVID-19 vaccine, including those identified by 91320, and replaces all previous, vaccine-specific administration codes.

CPT code 91320 is not used for pediatric doses. It specifically describes the Pfizer-BioNTech COVID-19 vaccine in a 30 mcg/0.3 mL tris-sucrose formulation for intramuscular use in patients 12 years and older.

No, CPT code 91320 does not include administration. It is a product code that only describes the vaccine itself. The administration of the vaccine must be reported separately using code 90480, which covers the work of giving the vaccine, counseling, and related services.